(5) K.Skrlec et al (2018) Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities Applied Microbiology and Biotechnology, 06 September 2018, Volume 102, pages 101031011
Drmic et al., Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME, World J
If you get digestive symptoms after taking B12, often there is a bacterial overgrowth or possibly fungal overgrowth creating the digestive symptoms
Without such a system, the absorption of supplemental B12 can be inconsistent and inadequate, particularly in individuals with compromised GI function or those with conditions that impair the production of IF